| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.91M | - | |
| VP | 79.5K | $767.2K | - | |
| VP | 67.4K | $650.3K | - | |
| VP | 65.1K | $628.0K | - | |
| VP | 56.3K | $543.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $14.79 | $147,872.00 | -1.9% | |
| Feb 20, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $14.79 | $147,872.00 | -1.9% | |
| Feb 16, 2018 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sell | 2,500 | $15.01 | $37,526.99 | -13.3% | |
| Feb 8, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 1,500 | $14.00 | $21,000.00 | -100% | |
| Feb 7, 2018 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sell | 1,500 | $13.00 | $19,500.00 | -13.2% | |
| Feb 7, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $12.50 | $125,048.00 | -1.4% | |
| Feb 7, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 1,500 | $13.00 | $19,500.00 | -100% | |
| Feb 7, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $12.50 | $125,048.00 | -1.4% | |
| Jan 18, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $10.09 | $100,882.00 | -1.9% | |
| Jan 18, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $10.09 | $100,882.00 | -1.9% |